Archives: Companies

Arafura Rare Earths Limited (Premium)



Ticker code: ARU

ARU Red Flags & Risk Indicators
✅
⚠️ RED FLAGS: 0 identified

No red flags detected.

Income Statement
Revenue 2024 Per Share Revenue 2025e Per Share Revenue 2026e Per Share Revenue 24 to 25e [%] Revenue 25e to 26e [%] EBITDA 2024 Per Share EBITDA 2025e Per Share EBITDA 2026e Per Share EBITDA 24 to 25e [%] EBITDA 25e to 26e [%]
None None None None None None None None None None
ARU Revenue Per Share (2012–2027)

Arafura Rare Earths Limited (ARU) Revenue Chart 2012–2027
ARU Earnings before Interest, Tax, Depreciation and Amortisation (EBITDA) Per Share (2012–2027)

Arafura Rare Earths Limited (ARU) EBITDA Chart 2012–2027
ARU Normalised Earnings Per Share (EPS) (2012–2027)

Arafura Rare Earths Limited (ARU) Normalised EPS Chart (2012–2027)

Valuation
Price To Sales Price To Book PER 2023 PER 2024 13Y Median PER Low PER 2025e 13Y Median PER High PER 2026e Last Updated
None 4.7 None None None None None None None
ARU Yearly Price Earnings Ratio (PER) Highs and Lows

Arafura Rare Earths Limited (ARU) PER Highs and Lows (2012–2027)
ARU Weekly Price Chart with Average True Range (ATR) Trailing Stop (10-Year View)
Arafura Rare Earths Limited (ARU) 10-Year Weekly ATR Trailing Stop Price Chart


Global X Semiconductor ETF (Premium)



Ticker code: SEMI

SEMI Red Flags & Risk Indicators
✅
⚠️ RED FLAGS: 0 identified

No red flags detected.

Income Statement
Revenue 2024 Per Share Revenue 2025e Per Share Revenue 2026e Per Share Revenue 24 to 25e [%] Revenue 25e to 26e [%] EBITDA 2024 Per Share EBITDA 2025e Per Share EBITDA 2026e Per Share EBITDA 24 to 25e [%] EBITDA 25e to 26e [%]
None None None None None None None None None None
SEMI Revenue Per Share (2012–2027)

Global X Semiconductor ETF (SEMI) Revenue Chart 2012–2027
SEMI Earnings before Interest, Tax, Depreciation and Amortisation (EBITDA) Per Share (2012–2027)

Global X Semiconductor ETF (SEMI) EBITDA Chart 2012–2027
SEMI Normalised Earnings Per Share (EPS) (2012–2027)

Global X Semiconductor ETF (SEMI) Normalised EPS Chart (2012–2027)

Valuation
Price To Sales Price To Book PER 2023 PER 2024 13Y Median PER Low PER 2025e 13Y Median PER High PER 2026e Last Updated
None None None None None None None None None
SEMI Yearly Price Earnings Ratio (PER) Highs and Lows

Global X Semiconductor ETF (SEMI) PER Highs and Lows (2012–2027)
SEMI Weekly Price Chart with Average True Range (ATR) Trailing Stop (10-Year View)
Global X Semiconductor ETF (SEMI) 10-Year Weekly ATR Trailing Stop Price Chart


Austco Healthcare Limited (Premium)



Ticker code: AHC

AHC Red Flags & Risk Indicators
⚠️
⚠️ RED FLAGS: 1 identified

  • High Relative Valuation

Income Statement
Revenue 2024 Per Share Revenue 2025e Per Share Revenue 2026e Per Share Revenue 24 to 25e [%] Revenue 25e to 26e [%] EBITDA 2024 Per Share EBITDA 2025e Per Share EBITDA 2026e Per Share EBITDA 24 to 25e [%] EBITDA 25e to 26e [%]
0.16131 0.22564 0.28419 39.9 25.9 0.02231 0.03611 0.0523 61.9 44.8
AHC Revenue Per Share (2012–2027)
✅✅
Austco Healthcare Limited (AHC) Revenue Chart 2012–2027
AHC Earnings before Interest, Tax, Depreciation and Amortisation (EBITDA) Per Share (2012–2027)
✅✅
Austco Healthcare Limited (AHC) EBITDA Chart 2012–2027
AHC Normalised Earnings Per Share (EPS) (2012–2027)
❌
Austco Healthcare Limited (AHC) Normalised EPS Chart (2012–2027)

Valuation
Price To Sales Price To Book PER 2023 PER 2024 13Y Median PER Low PER 2025e 13Y Median PER High PER 2026e Last Updated
2.0 3.1 43.5 21.8 8.8 21.8 13.4 14.5 4/10/25
AHC Yearly Price Earnings Ratio (PER) Highs and Lows
❌
Austco Healthcare Limited (AHC) PER Highs and Lows (2012–2027)
AHC Weekly Price Chart with Average True Range (ATR) Trailing Stop (10-Year View)
Austco Healthcare Limited (AHC) 10-Year Weekly ATR Trailing Stop Price Chart


Cuscal Limited (Premium)



Ticker code: CCL

CCL Red Flags & Risk Indicators
❌
⚠️ RED FLAGS: 3 identified

  • Negative Operating Cash Flow
  • High Relative Valuation
  • Falling EBITDA Margins

Income Statement
Revenue 2024 Per Share Revenue 2025e Per Share Revenue 2026e Per Share Revenue 24 to 25e [%] Revenue 25e to 26e [%] EBITDA 2024 Per Share EBITDA 2025e Per Share EBITDA 2026e Per Share EBITDA 24 to 25e [%] EBITDA 25e to 26e [%]
1.39624 1.51596 1.57244 8.6 3.7 0.33067 0.34297 0.38045 3.7 10.9
CCL Revenue Per Share (2012–2027)
✅
Cuscal Limited (CCL) Revenue Chart 2012–2027
CCL Earnings before Interest, Tax, Depreciation and Amortisation (EBITDA) Per Share (2012–2027)
✅
Cuscal Limited (CCL) EBITDA Chart 2012–2027
CCL Normalised Earnings Per Share (EPS) (2012–2027)
✅
Cuscal Limited (CCL) Normalised EPS Chart (2012–2027)

Valuation
Price To Sales Price To Book PER 2023 PER 2024 13Y Median PER Low PER 2025e 13Y Median PER High PER 2026e Last Updated
1.6 2.1 37.9 24.2 12.2 20.9 17.5 19.0 4/10/25
CCL Yearly Price Earnings Ratio (PER) Highs and Lows
❌
Cuscal Limited (CCL) PER Highs and Lows (2012–2027)
CCL Weekly Price Chart with Average True Range (ATR) Trailing Stop (10-Year View)
Cuscal Limited (CCL) 10-Year Weekly ATR Trailing Stop Price Chart


St George Mining Limited (Premium)



Ticker code: SGQ

SGQ Red Flags & Risk Indicators
✅
⚠️ RED FLAGS: 0 identified

No red flags detected.

Income Statement
Revenue 2024 Per Share Revenue 2025e Per Share Revenue 2026e Per Share Revenue 24 to 25e [%] Revenue 25e to 26e [%] EBITDA 2024 Per Share EBITDA 2025e Per Share EBITDA 2026e Per Share EBITDA 24 to 25e [%] EBITDA 25e to 26e [%]
None None None None None None None None None None
SGQ Revenue Per Share (2012–2027)

St George Mining Limited (SGQ) Revenue Chart 2012–2027
SGQ Earnings before Interest, Tax, Depreciation and Amortisation (EBITDA) Per Share (2012–2027)

St George Mining Limited (SGQ) EBITDA Chart 2012–2027
SGQ Normalised Earnings Per Share (EPS) (2012–2027)

St George Mining Limited (SGQ) Normalised EPS Chart (2012–2027)

Valuation
Price To Sales Price To Book PER 2023 PER 2024 13Y Median PER Low PER 2025e 13Y Median PER High PER 2026e Last Updated
3993.9 9.5 None None None None None None None
SGQ Yearly Price Earnings Ratio (PER) Highs and Lows

St George Mining Limited (SGQ) PER Highs and Lows (2012–2027)
SGQ Weekly Price Chart with Average True Range (ATR) Trailing Stop (10-Year View)
St George Mining Limited (SGQ) 10-Year Weekly ATR Trailing Stop Price Chart


Syntara Limited (Premium)



Ticker code: SNT

SNT Red Flags & Risk Indicators
❌
⚠️ RED FLAGS: 5 identified

  • Negative Operating Cash Flow
  • Low Operating Margin
  • Falling Revenues
  • Risk Of Capital Raise
  • Falling EBITDA Margins

Income Statement
Revenue 2024 Per Share Revenue 2025e Per Share Revenue 2026e Per Share Revenue 24 to 25e [%] Revenue 25e to 26e [%] EBITDA 2024 Per Share EBITDA 2025e Per Share EBITDA 2026e Per Share EBITDA 24 to 25e [%] EBITDA 25e to 26e [%]
0.0049 0.00187 None -61.9 None -0.0127 -0.00738 -0.01278 41.9 -73.2
SNT Revenue Per Share (2012–2027)
❌
Syntara Limited (SNT) Revenue Chart 2012–2027
SNT Earnings before Interest, Tax, Depreciation and Amortisation (EBITDA) Per Share (2012–2027)
✅✅
Syntara Limited (SNT) EBITDA Chart 2012–2027
SNT Normalised Earnings Per Share (EPS) (2012–2027)
❌
Syntara Limited (SNT) Normalised EPS Chart (2012–2027)

Valuation
Price To Sales Price To Book PER 2023 PER 2024 13Y Median PER Low PER 2025e 13Y Median PER High PER 2026e Last Updated
6.7 3.0 -1.5 -3.0 5.0 -3.0 7.2 -3.0 4/10/25
SNT Yearly Price Earnings Ratio (PER) Highs and Lows
✅✅
Syntara Limited (SNT) PER Highs and Lows (2012–2027)
SNT Weekly Price Chart with Average True Range (ATR) Trailing Stop (10-Year View)
Syntara Limited (SNT) 10-Year Weekly ATR Trailing Stop Price Chart


CRISPR Therapeutics AG (Premium)



Ticker code: CRSP

CRSP Red Flags & Risk Indicators
⚠️
⚠️ RED FLAGS: 2 identified

  • Low Operating Margin
  • Falling Earnings

Income Statement
Revenue 2024 Per Share Revenue 2025e Per Share Revenue 2026e Per Share Revenue 24 to 25e [%] Revenue 25e to 26e [%] EBITDA 2024 Per Share EBITDA 2025e Per Share EBITDA 2026e Per Share EBITDA 24 to 25e [%] EBITDA 25e to 26e [%]
0.43714 0.55624 2.0067 27.2 260.8 -5.44745 -4.86327 -3.15875 10.7 35.0
CRSP Revenue Per Share (2012–2027)
✅✅
CRISPR Therapeutics AG (CRSP) Revenue Chart 2012–2027
CRSP Earnings before Interest, Tax, Depreciation and Amortisation (EBITDA) Per Share (2012–2027)
✅
CRISPR Therapeutics AG (CRSP) EBITDA Chart 2012–2027
CRSP Normalised Earnings Per Share (EPS) (2012–2027)
✅
CRISPR Therapeutics AG (CRSP) Normalised EPS Chart (2012–2027)

Valuation
Price To Sales Price To Book PER 2023 PER 2024 13Y Median PER Low PER 2025e 13Y Median PER High PER 2026e Last Updated
146.0 3.2 -31.5 -11.9 17.6 -12.2 49.2 -22.4 13/11/24
CRSP Yearly Price Earnings Ratio (PER) Highs and Lows
✅✅
CRISPR Therapeutics AG (CRSP) PER Highs and Lows (2012–2027)
CRSP Weekly Price Chart with Average True Range (ATR) Trailing Stop (10-Year View)
CRISPR Therapeutics AG (CRSP) 10-Year Weekly ATR Trailing Stop Price Chart


Spartan Resources Limited (Premium)



Ticker code: CRSP

CRSP Red Flags & Risk Indicators
⚠️
⚠️ RED FLAGS: 1 identified

  • Low Operating Margin

Income Statement
Revenue 2024 Per Share Revenue 2025e Per Share Revenue 2026e Per Share Revenue 24 to 25e [%] Revenue 25e to 26e [%] EBITDA 2024 Per Share EBITDA 2025e Per Share EBITDA 2026e Per Share EBITDA 24 to 25e [%] EBITDA 25e to 26e [%]
0.43714 0.55624 2.0067 27.2 260.8 -5.44745 -4.86327 -3.15875 10.7 35.0
CRSP Revenue Per Share (2012–2027)
✅✅
Spartan Resources Limited (CRSP) Revenue Chart 2012–2027
CRSP Earnings before Interest, Tax, Depreciation and Amortisation (EBITDA) Per Share (2012–2027)
✅
Spartan Resources Limited (CRSP) EBITDA Chart 2012–2027
CRSP Normalised Earnings Per Share (EPS) (2012–2027)
✅
Spartan Resources Limited (CRSP) Normalised EPS Chart (2012–2027)

Valuation
Price To Sales Price To Book PER 2023 PER 2024 13Y Median PER Low PER 2025e 13Y Median PER High PER 2026e Last Updated
145.9 3.2 -31.5 -11.9 17.6 -12.2 49.2 -22.4 13/11/24
CRSP Yearly Price Earnings Ratio (PER) Highs and Lows
✅✅
Spartan Resources Limited (CRSP) PER Highs and Lows (2012–2027)
CRSP Weekly Price Chart with Average True Range (ATR) Trailing Stop (10-Year View)
Spartan Resources Limited (CRSP) 10-Year Weekly ATR Trailing Stop Price Chart


Catalyst Metals Limited (Premium)



Ticker code: CYL

CYL Red Flags & Risk Indicators
✅
⚠️ RED FLAGS: 0 identified

No red flags detected.

Income Statement
Revenue 2024 Per Share Revenue 2025e Per Share Revenue 2026e Per Share Revenue 24 to 25e [%] Revenue 25e to 26e [%] EBITDA 2024 Per Share EBITDA 2025e Per Share EBITDA 2026e Per Share EBITDA 24 to 25e [%] EBITDA 25e to 26e [%]
1.41144 1.7674 2.33738 25.2 32.2 0.27934 0.76689 1.20393 174.5 57.0
CYL Revenue Per Share (2012–2027)
✅✅
Catalyst Metals Limited (CYL) Revenue Chart 2012–2027
CYL Earnings before Interest, Tax, Depreciation and Amortisation (EBITDA) Per Share (2012–2027)
✅✅
Catalyst Metals Limited (CYL) EBITDA Chart 2012–2027
CYL Normalised Earnings Per Share (EPS) (2012–2027)
✅✅
Catalyst Metals Limited (CYL) Normalised EPS Chart (2012–2027)

Valuation
Price To Sales Price To Book PER 2023 PER 2024 13Y Median PER Low PER 2025e 13Y Median PER High PER 2026e Last Updated
4.8 3.6 None 45.3 3.1 13.6 12.2 9.3 20/9/25
CYL Yearly Price Earnings Ratio (PER) Highs and Lows
❌
Catalyst Metals Limited (CYL) PER Highs and Lows (2012–2027)
CYL Weekly Price Chart with Average True Range (ATR) Trailing Stop (10-Year View)
Catalyst Metals Limited (CYL) 10-Year Weekly ATR Trailing Stop Price Chart


WA1 Resources Ltd (Premium)



Ticker code: WA1

WA1 Red Flags & Risk Indicators
✅
⚠️ RED FLAGS: 0 identified

No red flags detected.

Income Statement
Revenue 2024 Per Share Revenue 2025e Per Share Revenue 2026e Per Share Revenue 24 to 25e [%] Revenue 25e to 26e [%] EBITDA 2024 Per Share EBITDA 2025e Per Share EBITDA 2026e Per Share EBITDA 24 to 25e [%] EBITDA 25e to 26e [%]
None None None None None None None None None None
WA1 Revenue Per Share (2012–2027)

WA1 Resources Ltd (WA1) Revenue Chart 2012–2027
WA1 Earnings before Interest, Tax, Depreciation and Amortisation (EBITDA) Per Share (2012–2027)

WA1 Resources Ltd (WA1) EBITDA Chart 2012–2027
WA1 Normalised Earnings Per Share (EPS) (2012–2027)

WA1 Resources Ltd (WA1) Normalised EPS Chart (2012–2027)

Valuation
Price To Sales Price To Book PER 2023 PER 2024 13Y Median PER Low PER 2025e 13Y Median PER High PER 2026e Last Updated
None 8.1 None None None None None None None
WA1 Yearly Price Earnings Ratio (PER) Highs and Lows

WA1 Resources Ltd (WA1) PER Highs and Lows (2012–2027)
WA1 Weekly Price Chart with Average True Range (ATR) Trailing Stop (10-Year View)
WA1 Resources Ltd (WA1) 10-Year Weekly ATR Trailing Stop Price Chart


MAC Copper Limited (Premium)



Ticker code: MAC

MAC Red Flags & Risk Indicators
✅
⚠️ RED FLAGS: 0 identified

No red flags detected.

Income Statement
Revenue 2024 Per Share Revenue 2025e Per Share Revenue 2026e Per Share Revenue 24 to 25e [%] Revenue 25e to 26e [%] EBITDA 2024 Per Share EBITDA 2025e Per Share EBITDA 2026e Per Share EBITDA 24 to 25e [%] EBITDA 25e to 26e [%]
None None None None None None None None None None
MAC Revenue Per Share (2012–2027)

MAC Copper Limited (MAC) Revenue Chart 2012–2027
MAC Earnings before Interest, Tax, Depreciation and Amortisation (EBITDA) Per Share (2012–2027)

MAC Copper Limited (MAC) EBITDA Chart 2012–2027
MAC Normalised Earnings Per Share (EPS) (2012–2027)

MAC Copper Limited (MAC) Normalised EPS Chart (2012–2027)

Valuation
Price To Sales Price To Book PER 2023 PER 2024 13Y Median PER Low PER 2025e 13Y Median PER High PER 2026e Last Updated
4.8 3.2 None None None None None None None
MAC Yearly Price Earnings Ratio (PER) Highs and Lows

MAC Copper Limited (MAC) PER Highs and Lows (2012–2027)
MAC Weekly Price Chart with Average True Range (ATR) Trailing Stop (10-Year View)
MAC Copper Limited (MAC) 10-Year Weekly ATR Trailing Stop Price Chart


IperionX Limited (Premium)



Ticker code: IPX

IPX Red Flags & Risk Indicators
❌
⚠️ RED FLAGS: 7 identified

  • Negative Operating Cash Flow
  • Large Share Issuance
  • Highly Shorted
  • Increasing Shorts
  • Zero Revenue
  • Falling Earnings
  • High Price to Book vs ROE

Income Statement
Revenue 2024 Per Share Revenue 2025e Per Share Revenue 2026e Per Share Revenue 24 to 25e [%] Revenue 25e to 26e [%] EBITDA 2024 Per Share EBITDA 2025e Per Share EBITDA 2026e Per Share EBITDA 24 to 25e [%] EBITDA 25e to 26e [%]
None None 0.05884 None None -0.08383 -0.1135 -0.039 -35.4 65.6
IPX Revenue Per Share (2012–2027)

IperionX Limited (IPX) Revenue Chart 2012–2027
IPX Earnings before Interest, Tax, Depreciation and Amortisation (EBITDA) Per Share (2012–2027)
❌
IperionX Limited (IPX) EBITDA Chart 2012–2027
IPX Normalised Earnings Per Share (EPS) (2012–2027)
❌
IperionX Limited (IPX) Normalised EPS Chart (2012–2027)

Valuation
Price To Sales Price To Book PER 2023 PER 2024 13Y Median PER Low PER 2025e 13Y Median PER High PER 2026e Last Updated
None 23.5 None -68.0 None -56.7 None -170.0 6/10/25
IPX Yearly Price Earnings Ratio (PER) Highs and Lows

IperionX Limited (IPX) PER Highs and Lows (2012–2027)
IPX Weekly Price Chart with Average True Range (ATR) Trailing Stop (10-Year View)
IperionX Limited (IPX) 10-Year Weekly ATR Trailing Stop Price Chart


Immutep Limited (Premium)



Ticker code: IMM

IMM Red Flags & Risk Indicators
✅
⚠️ RED FLAGS: 0 identified

No red flags detected.

Income Statement
Revenue 2024 Per Share Revenue 2025e Per Share Revenue 2026e Per Share Revenue 24 to 25e [%] Revenue 25e to 26e [%] EBITDA 2024 Per Share EBITDA 2025e Per Share EBITDA 2026e Per Share EBITDA 24 to 25e [%] EBITDA 25e to 26e [%]
None None None None None None None None None None
IMM Revenue Per Share (2012–2027)

Immutep Limited (IMM) Revenue Chart 2012–2027
IMM Earnings before Interest, Tax, Depreciation and Amortisation (EBITDA) Per Share (2012–2027)

Immutep Limited (IMM) EBITDA Chart 2012–2027
IMM Normalised Earnings Per Share (EPS) (2012–2027)

Immutep Limited (IMM) Normalised EPS Chart (2012–2027)

Valuation
Price To Sales Price To Book PER 2023 PER 2024 13Y Median PER Low PER 2025e 13Y Median PER High PER 2026e Last Updated
81.7 2.9 None None None None None None None
IMM Yearly Price Earnings Ratio (PER) Highs and Lows

Immutep Limited (IMM) PER Highs and Lows (2012–2027)
IMM Weekly Price Chart with Average True Range (ATR) Trailing Stop (10-Year View)
Immutep Limited (IMM) 10-Year Weekly ATR Trailing Stop Price Chart


Guzman y Gomez (Holdings) Ltd (Premium)



Ticker code: GYG

GYG Red Flags & Risk Indicators
⚠️
⚠️ RED FLAGS: 2 identified

  • Highly Shorted
  • High Price to Book vs ROE

Income Statement
Revenue 2024 Per Share Revenue 2025e Per Share Revenue 2026e Per Share Revenue 24 to 25e [%] Revenue 25e to 26e [%] EBITDA 2024 Per Share EBITDA 2025e Per Share EBITDA 2026e Per Share EBITDA 24 to 25e [%] EBITDA 25e to 26e [%]
3.37475 4.34009 5.40636 28.6 24.6 0.44181 0.63285 0.83257 43.2 31.6
GYG Revenue Per Share (2012–2027)
✅✅
Guzman y Gomez (Holdings) Ltd (GYG) Revenue Chart 2012–2027
GYG Earnings before Interest, Tax, Depreciation and Amortisation (EBITDA) Per Share (2012–2027)
✅✅
Guzman y Gomez (Holdings) Ltd (GYG) EBITDA Chart 2012–2027
GYG Normalised Earnings Per Share (EPS) (2012–2027)
✅✅
Guzman y Gomez (Holdings) Ltd (GYG) Normalised EPS Chart (2012–2027)

Valuation
Price To Sales Price To Book PER 2023 PER 2024 13Y Median PER Low PER 2025e 13Y Median PER High PER 2026e Last Updated
5.9 7.1 None 381.7 206.9 222.7 377.7 99.0 4/10/25
GYG Yearly Price Earnings Ratio (PER) Highs and Lows
✅
Guzman y Gomez (Holdings) Ltd (GYG) PER Highs and Lows (2012–2027)
GYG Weekly Price Chart with Average True Range (ATR) Trailing Stop (10-Year View)
Guzman y Gomez (Holdings) Ltd (GYG) 10-Year Weekly ATR Trailing Stop Price Chart


Clarity Pharmaceuticals Ltd (Premium)



Ticker code: CU6

CU6 Red Flags & Risk Indicators
❌
⚠️ RED FLAGS: 7 identified

  • Negative Operating Cash Flow
  • Low Operating Margin
  • Highly Shorted
  • Zero Revenue
  • Falling Earnings
  • Falling Revenues
  • High Price to Book vs ROE

Income Statement
Revenue 2024 Per Share Revenue 2025e Per Share Revenue 2026e Per Share Revenue 24 to 25e [%] Revenue 25e to 26e [%] EBITDA 2024 Per Share EBITDA 2025e Per Share EBITDA 2026e Per Share EBITDA 24 to 25e [%] EBITDA 25e to 26e [%]
None None 0.00207 None None -0.1344 -0.17442 -0.20832 -29.8 -19.4
CU6 Revenue Per Share (2012–2027)

Clarity Pharmaceuticals Ltd (CU6) Revenue Chart 2012–2027
CU6 Earnings before Interest, Tax, Depreciation and Amortisation (EBITDA) Per Share (2012–2027)
❌
Clarity Pharmaceuticals Ltd (CU6) EBITDA Chart 2012–2027
CU6 Normalised Earnings Per Share (EPS) (2012–2027)
❌
Clarity Pharmaceuticals Ltd (CU6) Normalised EPS Chart (2012–2027)

Valuation
Price To Sales Price To Book PER 2023 PER 2024 13Y Median PER Low PER 2025e 13Y Median PER High PER 2026e Last Updated
192.6 17.4 -49.0 -30.6 None -27.2 None -17.5 18/7/25
CU6 Yearly Price Earnings Ratio (PER) Highs and Lows

Clarity Pharmaceuticals Ltd (CU6) PER Highs and Lows (2012–2027)
CU6 Weekly Price Chart with Average True Range (ATR) Trailing Stop (10-Year View)
Clarity Pharmaceuticals Ltd (CU6) 10-Year Weekly ATR Trailing Stop Price Chart


Capstone Copper Corp. (Premium)



Ticker code: CSC

CSC Red Flags & Risk Indicators
✅
⚠️ RED FLAGS: 0 identified

No red flags detected.

Income Statement
Revenue 2024 Per Share Revenue 2025e Per Share Revenue 2026e Per Share Revenue 24 to 25e [%] Revenue 25e to 26e [%] EBITDA 2024 Per Share EBITDA 2025e Per Share EBITDA 2026e Per Share EBITDA 24 to 25e [%] EBITDA 25e to 26e [%]
None None None None None None None None None None
CSC Revenue Per Share (2012–2027)

Capstone Copper Corp. (CSC) Revenue Chart 2012–2027
CSC Earnings before Interest, Tax, Depreciation and Amortisation (EBITDA) Per Share (2012–2027)

Capstone Copper Corp. (CSC) EBITDA Chart 2012–2027
CSC Normalised Earnings Per Share (EPS) (2012–2027)

Capstone Copper Corp. (CSC) Normalised EPS Chart (2012–2027)

Valuation
Price To Sales Price To Book PER 2023 PER 2024 13Y Median PER Low PER 2025e 13Y Median PER High PER 2026e Last Updated
5.4 3.4 None None None None None None None
CSC Yearly Price Earnings Ratio (PER) Highs and Lows

Capstone Copper Corp. (CSC) PER Highs and Lows (2012–2027)
CSC Weekly Price Chart with Average True Range (ATR) Trailing Stop (10-Year View)
Capstone Copper Corp. (CSC) 10-Year Weekly ATR Trailing Stop Price Chart


Meteoric Resources NL (Premium)



Ticker code: MEI

MEI Red Flags & Risk Indicators
✅
⚠️ RED FLAGS: 0 identified

No red flags detected.

Income Statement
Revenue 2024 Per Share Revenue 2025e Per Share Revenue 2026e Per Share Revenue 24 to 25e [%] Revenue 25e to 26e [%] EBITDA 2024 Per Share EBITDA 2025e Per Share EBITDA 2026e Per Share EBITDA 24 to 25e [%] EBITDA 25e to 26e [%]
None None None None None None None None None None
MEI Revenue Per Share (2012–2027)

Meteoric Resources NL (MEI) Revenue Chart 2012–2027
MEI Earnings before Interest, Tax, Depreciation and Amortisation (EBITDA) Per Share (2012–2027)

Meteoric Resources NL (MEI) EBITDA Chart 2012–2027
MEI Normalised Earnings Per Share (EPS) (2012–2027)

Meteoric Resources NL (MEI) Normalised EPS Chart (2012–2027)

Valuation
Price To Sales Price To Book PER 2023 PER 2024 13Y Median PER Low PER 2025e 13Y Median PER High PER 2026e Last Updated
17429.6 50.0 None None None None None None None
MEI Yearly Price Earnings Ratio (PER) Highs and Lows

Meteoric Resources NL (MEI) PER Highs and Lows (2012–2027)
MEI Weekly Price Chart with Average True Range (ATR) Trailing Stop (10-Year View)
Meteoric Resources NL (MEI) 10-Year Weekly ATR Trailing Stop Price Chart


Abacus Group (Premium)



Ticker code: ABG

ABG Red Flags & Risk Indicators
✅
⚠️ RED FLAGS: 0 identified

No red flags detected.

Income Statement
Revenue 2024 Per Share Revenue 2025e Per Share Revenue 2026e Per Share Revenue 24 to 25e [%] Revenue 25e to 26e [%] EBITDA 2024 Per Share EBITDA 2025e Per Share EBITDA 2026e Per Share EBITDA 24 to 25e [%] EBITDA 25e to 26e [%]
None None None None None None None None None None
ABG Revenue Per Share (2012–2027)

Abacus Group (ABG) Revenue Chart 2012–2027
ABG Earnings before Interest, Tax, Depreciation and Amortisation (EBITDA) Per Share (2012–2027)

Abacus Group (ABG) EBITDA Chart 2012–2027
ABG Normalised Earnings Per Share (EPS) (2012–2027)

Abacus Group (ABG) Normalised EPS Chart (2012–2027)

Valuation
Price To Sales Price To Book PER 2023 PER 2024 13Y Median PER Low PER 2025e 13Y Median PER High PER 2026e Last Updated
4.3 0.7 None None None None None None None
ABG Yearly Price Earnings Ratio (PER) Highs and Lows

Abacus Group (ABG) PER Highs and Lows (2012–2027)
ABG Weekly Price Chart with Average True Range (ATR) Trailing Stop (10-Year View)
Abacus Group (ABG) 10-Year Weekly ATR Trailing Stop Price Chart


HealthCo Healthcare and Wellness REIT (Premium)



Ticker code: HCW

HCW Red Flags & Risk Indicators
✅
⚠️ RED FLAGS: 0 identified

No red flags detected.

Income Statement
Revenue 2024 Per Share Revenue 2025e Per Share Revenue 2026e Per Share Revenue 24 to 25e [%] Revenue 25e to 26e [%] EBITDA 2024 Per Share EBITDA 2025e Per Share EBITDA 2026e Per Share EBITDA 24 to 25e [%] EBITDA 25e to 26e [%]
None None None None None None None None None None
HCW Revenue Per Share (2012–2027)

HealthCo Healthcare and Wellness REIT (HCW) Revenue Chart 2012–2027
HCW Earnings before Interest, Tax, Depreciation and Amortisation (EBITDA) Per Share (2012–2027)

HealthCo Healthcare and Wellness REIT (HCW) EBITDA Chart 2012–2027
HCW Normalised Earnings Per Share (EPS) (2012–2027)

HealthCo Healthcare and Wellness REIT (HCW) Normalised EPS Chart (2012–2027)

Valuation
Price To Sales Price To Book PER 2023 PER 2024 13Y Median PER Low PER 2025e 13Y Median PER High PER 2026e Last Updated
6.2 0.5 None None None None None None None
HCW Yearly Price Earnings Ratio (PER) Highs and Lows

HealthCo Healthcare and Wellness REIT (HCW) PER Highs and Lows (2012–2027)
HCW Weekly Price Chart with Average True Range (ATR) Trailing Stop (10-Year View)
HealthCo Healthcare and Wellness REIT (HCW) 10-Year Weekly ATR Trailing Stop Price Chart


Redox Limited (Premium)



Ticker code: RDX

RDX Red Flags & Risk Indicators
❌
⚠️ RED FLAGS: 4 identified

  • Large Share Issuance
  • Increasing Shorts
  • Falling Earnings
  • Falling EBITDA Margins

Income Statement
Revenue 2024 Per Share Revenue 2025e Per Share Revenue 2026e Per Share Revenue 24 to 25e [%] Revenue 25e to 26e [%] EBITDA 2024 Per Share EBITDA 2025e Per Share EBITDA 2026e Per Share EBITDA 24 to 25e [%] EBITDA 25e to 26e [%]
2.16601 2.3658 2.65277 9.2 12.1 0.26463 0.26954 0.29395 1.9 9.1
RDX Revenue Per Share (2012–2027)
✅
Redox Limited (RDX) Revenue Chart 2012–2027
RDX Earnings before Interest, Tax, Depreciation and Amortisation (EBITDA) Per Share (2012–2027)
✅
Redox Limited (RDX) EBITDA Chart 2012–2027
RDX Normalised Earnings Per Share (EPS) (2012–2027)
❌
Redox Limited (RDX) Normalised EPS Chart (2012–2027)

Valuation
Price To Sales Price To Book PER 2023 PER 2024 13Y Median PER Low PER 2025e 13Y Median PER High PER 2026e Last Updated
1.2 2.8 14.5 16.1 12.1 18.1 21.2 17.0 6/11/24
RDX Yearly Price Earnings Ratio (PER) Highs and Lows
✅
Redox Limited (RDX) PER Highs and Lows (2012–2027)
RDX Weekly Price Chart with Average True Range (ATR) Trailing Stop (10-Year View)
Redox Limited (RDX) 10-Year Weekly ATR Trailing Stop Price Chart